Navigation Links
Testes stem cell can change into other body tissues, Stanford/UCSF study shows
Date:1/5/2009

STANFORD, Calif. Scientists at the Stanford University School of Medicine and at UC-San Francisco have succeeded in isolating stem cells from human testes. The cells bear a striking resemblance to embryonic stem cells they can differentiate into each of the three main types of tissues of the body but the researchers caution against viewing them as one and the same.

According to the study, the testes stem cells have different patterns of gene expression and regulation and they do not proliferate and differentiate as aggressively as human embryonic stem cells.

The findings, published in the January issue of the journal Stem Cells, are in contrast to those reported in a recent Nature paper, which concluded that the cells were, in fact, as pluripotent as embryonic stem cells. Pluripotent cells can become any cell in the body and form tumors called teratomas when transplanted into mice.

"It's time to reinterpret the data," said Renee Reijo-Pera, PhD, professor of obstetrics & gynecology at Stanford, "and to accept that we're beginning to discover many different types of stem cells. Although they are all related to each other, they also all have unique therapeutic applications in which they surpass other family members."

Reijo-Pera, who is the director of Stanford's Center for Human Embryonic Stem Cell Research and Education, collaborated with male infertility specialist Paul Turek, MD, a professor of urology at UCSF and the director of The Turek Clinic in San Francisco, to conduct the research. Reijo-Pera and Turek are co-senior authors of the study.

The stem cells from the testes seem to hover in a gray area between true pluripotency and the more limited, tissue-specific multipotency exhibited by many types of adult stem cells. They termed the cells "multipotent germline stem cells." Germ cells are those cells in the body that differentiate to make sperm and eggs.

Playing to these cells' strengths in
'/>"/>

Contact: Krista Conger
kristac@stanford.edu
650-725-5371
Stanford University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Researchers Create Embryonic-Like Stem Cells From Human Testes
2. Stem Cells From Testes Produce Wide Range of Tissue Types
3. Stem cells derived from adult testes produce wide range of tissue types
4. Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration
5. Cardium Reports on Exchange Listing With NYSE Alternext US
6. Climate Change May Boost Contact With Pollutants
7. Rules Change Could Increase Hospice Use
8. Parker College of Chiropractic Education Launches Recruiting Campaign for Career Changers and Potential Students
9. Dynatronics Announces Changes to Board and Launches Operational Improvement Process
10. Response Biomedical Corporation Announces Change of Executives
11. White Mountains Re Announces Management Changes -- Chokel to Retire and Remain Risk Advisor at WTM

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...Nov. 9 At a time when the 250,000+...ingly concerned about finding affordable health in...on for 2010. ,, The Today,s Options® Prefe...e plan provides a cost-effective and comprehensive...pplement plan. People with Medicare can choose to...
(Date:11/9/2009)... The American Academy of...an 75,000 clinically practicing physician assistan... the U.S. House of Representatives for passing Sat...Affordable Health Care for America Act. ,, "We ...l ultimately lower the cost of health care and gre...
(Date:11/9/2009)...earch Hospital and the University of Florida Proto... provide proton therapy for St. Jude patients. The...inical study to evaluate the use of proton therapy... years old. , Under the clinical protocol, St....y at the UF Proton Therapy Institute in Jacksonvil...
(Date:11/9/2009)...9, 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), the ...announced the availability of INTUNIV (guanfacine)... United States for the treatment of Attention-Defi...adolescents ages 6 to 17. INTUNIV, a once-daily f...nscheduled alpha-2A receptor agonist approved for ...
(Date:11/9/2009)... 2009 The first human embryonic stem cell treatme...shown to restore limb function in rats with neck s...he clinical trial to include people with cervical ...istration gave Geron Corp. of Menlo Park, Calif., ...viduals with thoracic spinal cord injuries, which ...
Breaking Medicine News(10 mins):Health News:Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option 2Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 3Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 4Health News:UCI embryonic stem cell therapy restores walking ability in rats with neck injuries 2
... China, Nov. 7 /Xinhua-PRNewswire-FirstCall/ -- Ch...lletin Board: CPHI), which,develops, manufactures,...ceutical products in China, today announced financ...lion Revenue for nine months ended September 30, u...
... health plans evaluated based on quality of care, ...oup and The,National Committee for Quality Assuran... of America,s Best Health Plans on USNews.com. Lau... provides,comprehensive rankings and important con...
...Fraxel laser treatment highlighted in several podi...gic Surgery,s Annual Meeting, ORLANDO, Fla., Nov....ctional resurfacing and market leader of aesthetic...ed at the,American Society for Dermatologic Surger...
...e brand with mangosteen BioActiveX3 Complex(TM) fe...chnology in self-adjusting ...nutrition leader XanGo,LLC, today announced the of...ingredients from the mangosteen delivered through,...
.... 7 NutraCea (OTC Bulletin Board:,NTRZ), a world ...arch and,technology, today announced financial res...8., Net revenues for the 2008 third quarter incre...venues from the,Company,s NutraCea segment and $7....
..., Mich., Nov. 7 The,patient-centered medical home... coverage will be among the topics at the annual "...igan State Medical Society (MSMS),on Tuesday, Nov....of the emerging health care model that ensures coo...
Other Medicine News:Health News:China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates 2Health News:China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates 3Health News:China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates 4Health News:China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates 5Health News:China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates 6Health News:China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates 7Health News:China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates 8Health News:China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates 9Health News:China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates 10Health News:U.S. News Media Group and NCQA Release 2008 Rankings for America's Best Health Plans 2Health News:U.S. News Media Group and NCQA Release 2008 Rankings for America's Best Health Plans 3Health News:Fraxel(R) Laser Systems Shown to Provide Superior Results Compared to 'Pseudo Fractional' Laser Technologies 2Health News:Fraxel(R) Laser Systems Shown to Provide Superior Results Compared to 'Pseudo Fractional' Laser Technologies 3Health News:Fraxel(R) Laser Systems Shown to Provide Superior Results Compared to 'Pseudo Fractional' Laser Technologies 4Health News:XanGo Introduces Glimpse(TM) Intuitive Skin Care 2Health News:XanGo Introduces Glimpse(TM) Intuitive Skin Care 3Health News:NutraCea Announces Third Quarter 2008 Financial Results 2Health News:NutraCea Announces Third Quarter 2008 Financial Results 3Health News:NutraCea Announces Third Quarter 2008 Financial Results 4Health News:NutraCea Announces Third Quarter 2008 Financial Results 5Health News:NutraCea Announces Third Quarter 2008 Financial Results 6Health News:NutraCea Announces Third Quarter 2008 Financial Results 7Health News:NutraCea Announces Third Quarter 2008 Financial Results 8Health News:NutraCea Announces Third Quarter 2008 Financial Results 9
(Date:11/9/2009)...ov. 9 PAREXEL Internatio... biopharmaceutical services provider, today announ...lities for early phase clinical development throug... manufactures and distributes electrocardiogram (E...XEL is using Mortara Instrument,s Surveyor Telemet...
(Date:11/7/2009)...CH, Fla., Nov. 7 Most patients wit...oms that signal an oncoming HAE attack giving the ... decrease the morbidity associated with that attac... the 2009 American College of Allergy, Asthma &...tion of symptoms such as fatigue and nausea, which...
(Date:11/6/2009)...N, Mass., Nov. 6 DUSA Ph...ermatology company that is developing and marketin...ther products focused on patients with common skin...nd Chief Executive Officer, will present a corpora...ummit 2009 on Tuesday, November 10, 2009 at 10:00 ...
Breaking Medicine Technology:PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 2PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 3PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 4PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument 5Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3BBV Vietnam S E A Acquisition Corp Announces Signing of Letter of Intent for Business Combination with Migami Inc 53392 1BBV Vietnam S E A Acquisition Corp Announces Signing of Letter of Intent for Business Combination with Migami Inc 53392 2Excaliard Pharmaceuticals Appoints Jay Birnbaum Ph D to the Board of Directors 53389 1Excaliard Pharmaceuticals Appoints Jay Birnbaum Ph D to the Board of Directors 53389 2Blood Transfusions Not Linked to Long Term Problems 53386 1
...s Overall Psychological Toll Is Greater Than for A...Pa., May 17, 2007 /PRNewswire/ -- Nearly three out...cent) responding to a,new nationwide survey say no...urthermore, they describe UC as disruptive when it...cent), their sexual,relations (75 percent) and the...
...USALEM--(BUSINESS WIRE)--May 17, 2007 - BioLineRx ...nt company, announced today,that abstracts contain...linical trails of BL-1020, first in class GABA-enh...enia, have been,accepted for poster presentations ...will be presented at the following,conferences:, -...
Other Medicine Technology:Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 2Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 3Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 4Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 5Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 6Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 7Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 8Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 9BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences 2BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences 3
CA-125 Enzyme Immunoassay Test Kit
Immulite PAP
Mosaic
...s a neurosurgical OR that fully integrates all the...cessary to treat complicated neurosurgical cases. ... performed in a workflow optimized manner. Pre-tes...BrainSUITE iMRI guarantees rapid implementation in...
Medicine Products: